
Fibrosis is a pathological feature of many chronic inflammatory diseases that results in scarring and hardening of tissues and organs. It is caused by the accumulation of excess extracellular matrix components, particularly collagen, leading to the formation of permanent fibrotic scars. Fibrosis can affect various parts of the body, including the lungs, liver, kidneys, brain, heart, and muscles. In the case of muscular fibrosis, it can be a devastating clinical problem, compromising muscle contractility, tissue architecture, and organ function. The process of muscle fibrosis is currently being studied to develop innovative anti-fibrotic therapies and improve our understanding of muscle diseases such as muscular dystrophies.
| Characteristics | Values |
|---|---|
| Definition | Scarring and hardening of tissues and organs due to the accumulation of excess extracellular matrix components, particularly collagen. |
| Causes | Repeated injuries, chronic inflammation, repair, and diseases. |
| Organs/Tissues Affected | Lungs, liver, kidneys, brain, heart, joints, tendons, shoulder capsule, skeletal muscle, intestine, intestine, blood capillaries, nerves, etc. |
| Related Disorders | End-stage liver disease, kidney disease, idiopathic pulmonary fibrosis, liver cirrhosis, heart failure, scleroderma, rheumatoid arthritis, Crohn's disease, myelofibrosis, systemic lupus erythematosus, Dupuytren's contracture, adhesive capsulitis, muscular dystrophies, myositis, megacystis-microcolon, etc. |
| Treatment | Physiotherapy, anti-fibrotic therapies, traditional Chinese medicine, and drugs. |
Explore related products
What You'll Learn

Skeletal muscle fibrosis
Fibrosis is the development of fibrous connective tissue in response to an injury. It is a natural wound healing response that can lead to scarring and thickening of the affected tissue. Fibrosis can occur in many tissues within the body, including the skeletal muscle.
The extracellular matrix (ECM) is an essential component of skeletal muscle. It provides a framework structure that holds myofibers, blood capillaries, and nerves supplying the muscle. Excessive accumulation of ECM components, especially collagens, is defined as fibrosis. Skeletal muscle fibrosis impairs muscle function, negatively affects muscle regeneration after injury, and increases muscle susceptibility to re-injury. It is considered a major cause of muscle weakness.
A UC Davis Health team is studying why special stem cells, known as fibro-adipogenic progenitors (FAPs), produce excess material that can lead to fibrosis instead of normal muscle regeneration following injury. The team found that FAPs detect the stiffness of the matrix, which helps explain the positive feedback and progressive nature of muscle fibrosis. They also tested the drug verteporfin, which can block the progenitors' stiffness sensing and may prevent fibrosis.
Exploring the Myth: Muscle Aches and Weight Gain
You may want to see also
Explore related products

Muscular dystrophies
Fibrosis is the development of fibrous connective tissue in response to an injury. It can be a normal connective tissue deposition or excessive tissue deposition caused by a disease. Muscular dystrophies are a group of more than 30 genetic conditions that cause progressive weakness and loss of muscle mass. The symptoms of muscular dystrophy get worse over time. It can be present at birth, develop in childhood, or develop in adulthood depending on the type.
Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy. It mainly affects boys, but girls can also have a milder version of it. As DMD progresses, it affects the heart and lungs. Becker muscular dystrophy (BMD) is the second most common type of muscular dystrophy. It mainly affects boys, but girls can have milder symptoms. Symptoms of BMD can appear anytime between the ages of 5 and 60, but they typically start in the teenage years.
Myotonic dystrophy is the most common type of muscular dystrophy that's diagnosed in adulthood. It affects men and women equally. People with myotonic dystrophy have difficulty relaxing their muscles after using them. The condition can also affect the heart and lungs and may cause endocrine issues, such as thyroid disease and diabetes.
Facioscapulohumeral muscular dystrophy (FSHD) most commonly affects muscles in the face, shoulders, and upper arms. Limb-girdle muscular dystrophy (LGMD) affects the muscles in the upper arms, upper legs, shoulders, and hips. Emery-Dreifuss muscular dystrophy (EDMD) mainly affects male children and young adults. It tends to cause muscle weakness in the shoulders, upper arms, and shins. EDMD also affects the heart.
Dehydration's Impact: Muscle Shrinkage and Performance
You may want to see also
Explore related products

Fibrosis in other organs
Fibrosis is the development of fibrous connective tissue in response to an injury. It can occur in many tissues within the body, typically as a result of inflammation or damage. It is defined by the accumulation of excess extracellular matrix components, particularly collagen, which can lead to permanent scarring and organ malfunction.
Fibrosis commonly occurs in the lungs, liver, kidneys, brain, and heart. In the lungs, it is known as pulmonary fibrosis and it damages the interstitial tissues, which are the cells that make up the space between blood vessels and other structures inside the lungs. This damage results in lung scarring, making it hard to breathe. Pulmonary fibrosis can be caused by smoking, regular exposure to dust or fumes, radiation exposure, certain medications, and viral infections. It is a rare disease, and diagnosis can be challenging as it may resemble other, more common lung diseases.
In the liver, fibrosis can occur through TGF-β-mediated pathways or independently of TGF-β through IL-13-mediated pathways. The liver has a unique capacity to regenerate, and liver fibrosis can be assessed using Picro Sirius Red Staining or transmission electron microscopy to identify cross-linked collagen fibers.
Fibrosis of the kidneys, or renal fibrosis, demonstrates a disparity between the organ's capacity to regenerate from severe acute injury and the irreversibility of fibrotic lesions. While the tubular basement membranes can be repopulated without scar formation, kidney fibrosis can result in permanent scarring and impaired organ function.
Cardiac fibrosis, or fibrosis of the heart, is characterized by distinct types of fibrotic lesions. Perivascular fibrosis, interstitial fibrosis, and subendocardial fibrosis can occur, with the latter being found in newborns with congenital heart defects. Cardiac fibroblasts are unique in that they also function as mechanoelectrical transducers, and their role is more obvious than in other organs.
Fibrosis can also affect the brain, with skeletal muscle fibrosis potentially resulting from brain injuries.
Dodge Viper: Muscle Car or Sports Car?
You may want to see also
Explore related products

Causes of fibrosis
Fibrosis is a pathological feature of many chronic inflammatory diseases and is characterised by the scarring and hardening of tissues and organs. It is caused by the excessive accumulation of fibrous connective tissue, specifically the excess production and deposition of collagenous extracellular matrix by myofibroblasts. This can lead to permanent scarring, organ malfunction and, in some cases, death.
There are several causes of fibrosis, including:
Drug-Induced
Certain drugs have been known to cause fibrosis, especially those used to treat cancer (chemotherapy), abnormal heart rhythms (e.g. amiodarone), inflammatory conditions (e.g. methotrexate), and urinary tract infections (e.g. nitrofurantoin).
Radiation-Induced
Radiation to the chest for treating cancers such as lymphoma, Hodgkin's disease, breast, lung, and others, can cause injury to the lungs and lead to fibrosis.
Environmental
Inhaled environmental substances can cause a form of pulmonary fibrosis called hypersensitivity pneumonitis (HP). This occurs when the lungs react with inflammation and scarring after breathing in substances like mould spores, bacteria, or animal proteins.
Autoimmune
Autoimmune diseases, also called connective tissue or collagen vascular diseases, can cause fibrosis when the body's immune system attacks its own lungs. Examples include rheumatoid arthritis, scleroderma, Sjogren's syndrome, and Crohn's disease.
Occupational
Exposure to hazardous materials in the workplace, such as asbestos or silica, can lead to pulmonary fibrosis.
It is important to note that in some cases of fibrosis, especially pulmonary fibrosis, the exact cause may remain unknown, and it is then termed "idiopathic".
Assessing Thigh Muscles: What to Feel and Look For
You may want to see also
Explore related products

Treatment of fibrosis
Fibrosis is the development of fibrous connective tissue in response to an injury. It is characterised by the accumulation of extracellular matrix components, particularly collagen, leading to permanent scarring and thickening of the affected tissue. While fibrosis is a natural wound healing process, it can interfere with normal organ function and even lead to organ malfunction and death.
Currently, there is no cure for fibrosis, and treatment strategies are limited. The focus of available treatments is on slowing the progression of the disease, relieving symptoms, and helping patients maintain an active and healthy lifestyle. Treatment options include:
- Medications: Depending on the type of fibrosis, certain medications may be prescribed to slow down the progression of the disease or alleviate symptoms.
- Oxygen Therapy: For conditions like pulmonary fibrosis, supplemental oxygen therapy can be prescribed to improve oxygen levels in the bloodstream and reduce shortness of breath.
- Pulmonary Rehabilitation: This involves educating patients about their lung disease, providing exercises to improve breathing, and offering support and counselling to help them manage their condition.
- Lung Transplant: In severe cases of pulmonary fibrosis, a lung transplant may be considered, although donor lungs are rare.
- Physiotherapy: Physiotherapy can play a role in minimising fibrotic changes, influencing scar tissue strength, and improving the patient's quality of life.
- Clinical Trials: Participating in clinical trials can provide access to new and emerging treatment options for pulmonary fibrosis.
- Nutrition and Exercise: Proper nutrition and exercise routines can positively impact the management of fibrosis, in addition to stress management and lung protection.
Fibrosis can affect various parts of the body, including the lungs, liver, kidneys, brain, heart, and muscles. Therefore, the treatment for fibrosis will vary depending on the specific organ or tissue affected and the severity of the condition.
What Muscles Make Up Your Latissimus Dorsi?
You may want to see also
Frequently asked questions
Fibrosis is the development of fibrous connective tissue in response to an injury. It is a natural wound healing response that can interfere with normal organ function.
Fibrosis is caused by repeated injuries, chronic inflammation, and repair processes that go awry. It is characterized by the excessive production and deposition of collagenous extracellular matrix, leading to permanent scarring.
Common sites of fibrosis include the lungs, liver, kidneys, brain, and heart. It can also affect skeletal muscles, causing muscle weakness and impairing muscle function.
Fibrosis of skeletal muscles can lead to muscle contractures, where a joint becomes permanently fixed and requires surgery. It also increases the risk of re-injury and negatively impacts muscle regeneration.
While fibrosis was historically considered irreversible, recent studies have demonstrated reversal in certain cases, such as in liver, lung, renal, myocardial, and oral-submucosal fibrosis. Physiotherapy and anti-fibrotic therapies can also help manage the condition.











































